How I Treat: Infections and inborn errors of immunity—Prevention, diagnosis, and treatment

Infections are a significant cause of morbidity and mortality in inborn errors of immunity (IEI). Prevention of infections relies on knowledge of the specific pathogen susceptibility of the IEI to then consider antimicrobial prophylaxis, immune modulation, and/or environmental measures. In addition, complications of IEI include bronchiectasis, which can lead to more infections due to disruption of mucociliary clearance; suppression of chronic infections and airway clearance measures are important parts of bronchiectasis management. We discuss some infections that are challenging to diagnose for patients with distinct IEI and how partnership with the microbiology laboratory can lead to more prompt diagnosis and specific management. Finally, the increasing ability to identify the molecular basis of IEI facilitates precise immunomodulation, which can attenuate the infection burden of these diseases yet can also add unique infection risks depending on the specific therapy.

Authors

Institutions

Publication Details

Journal
Journal of Human Immunity
Published
2025-11-25
DOI
https://doi.org/10.70962/jhi.20250137
Citations
1
Primary Topic
Immunodeficiency and Autoimmune Disorders
Type
article
Field-Weighted Citation Impact
0.80
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

How I Treat: Infections and inborn errors of immunity—Prevention, diagnosis, and treatment

Alexandra F. Freeman, Beth K Thielen, Tamara C. Pozos
1 citations
Journal of Human Immunity
Immunodeficiency and Autoimmune Disorders
0.80
article

How I Treat: Infections and inborn errors of immunity—Prevention, diagnosis, and treatment

Alexandra F. Freeman, Beth K Thielen, Tamara C. Pozos
article en
1 citations

Abstract

Infections are a significant cause of morbidity and mortality in inborn errors of immunity (IEI). Prevention of infections relies on knowledge of the specific pathogen susceptibility of the IEI to then consider antimicrobial prophylaxis, immune modulation, and/or environmental measures. In addition, complications of IEI include bronchiectasis, which can lead to more infections due to disruption of mucociliary clearance; suppression of chronic infections and airway clearance measures are important parts of bronchiectasis management. We discuss some infections that are challenging to diagnose for patients with distinct IEI and how partnership with the microbiology laboratory can lead to more prompt diagnosis and specific management. Finally, the increasing ability to identify the molecular basis of IEI facilitates precise immunomodulation, which can attenuate the infection burden of these diseases yet can also add unique infection risks depending on the specific therapy.

Journal of Human ImmunityVol. 2(1)
Children's Minnesota (US), National Institute of Allergy and Infectious Diseases (US), University of Minnesota Medical Center (US)
Openalex Percentile: Top 21%
Immunodeficiency and Autoimmune Disorders
0.80
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.